Overview

Impax Laboratories, LLC is a pharmaceutical company based in the United States that develops, manufactures, and markets bioequivalent and brand-name pharmaceuticals. It is a subsidiary of Amneal Pharmaceuticals LLC following their merger. The company focuses on providing therapies for central nervous system disorders and other conditions.

Therapeutic areas

Central Nervous SystemParkinson's DiseaseEpilepsyMigraine

FDA compliance signals

6 FDA enforcement records linked to this company.

  • recall — Class I2016-12-28

    Labeling; Label Mixup; box labeled to contain 200 mg blister packs but actually contain 100 mg blister packs

  • recall — Class II2016-04-27

    Failed Impurities/Degradation Specifications

  • recall — Class II2016-04-27

    Failed Impurities/Degradation Specifications

  • recall — Class III2016-04-20

    Labeling: Incorrect or Missing Lot and/or Exp. Date

  • recall — Class III2016-04-20

    Labeling: Incorrect or Missing Lot and/or Exp. Date

  • warning_letter2011-05-31

    FDA Warning Letter (drug product)

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.